Insights into recent findings and clinical application of YAP and TAZ in cancer
Crossref DOI link: https://doi.org/10.1038/s41568-023-00579-1
Published Online: 2023-06-12
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Franklin, J. Matthew
Wu, Zhengming
Guan, Kun-Liang http://orcid.org/0000-0003-1892-0174
Text and Data Mining valid from 2023-06-12
Version of Record valid from 2023-06-12
Article History
Accepted: 19 April 2023
First Online: 12 June 2023
Competing interests
: K.-L.G. is a co-founder of and has equity interest in Vivace Therapeutics. The other authors declare no competing interests.